{"schema_version":"secwatch.filing_event.v1","accession":"0001077183-25-000172","form_type":"8-K","ticker":"NEO","cik":"0001077183","company_name":"NEOGENOMICS INC","filed_at":"2025-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.736213+00:00","generated_at":"2026-05-17T01:51:40.845683+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NeoGenomics Q3 revenue up 12% to $188M; net loss widens 53% to $27M","bullets":["Revenue of $188M, +12% YoY; clinical revenue +18% and NGS +24% to ~1/3 of clinical.","Net loss $27M vs $18M, up 53%; adjusted EBITDA $12.2M, down 9% from $13.4M.","Reaffirmed FY 2025 guidance: revenue $720-726M, net loss $(116)-(108)M, adj EBITDA $41-44M.","OpEx +12% YoY, includes $7.1M impairment charge on Trapelo held-for-sale."],"urls":{"canonical":"https://secwatch.observer/filing/0001077183-25-000172","json":"https://secwatch.observer/filing/0001077183-25-000172.json","markdown":"https://secwatch.observer/filing/0001077183-25-000172.md","text":"https://secwatch.observer/filing/0001077183-25-000172.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000172/0001077183-25-000172-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000172/neo-20251028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:51:40.845683+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}